Alterity Therapeutics Key Ratios (2009-2025)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2016	Dec2016	Jun2017	Dec2017	Jun2018	Dec2018	Jun2019	Dec2019	Jun2020	Dec2020	Jun2021	Dec2021	Jun2022	Dec2022	Jun2023	Dec2023	Jun2024	Dec2024	Jun2025	Dec2025
Profitability
Gross Margin (Quarter)								-17,737,277,190,370.75%
EBT Margin (Quarter)		-208.71%		3,178.13%		-222.66%		-304.03%
EBIT Margin (Quarter)		-208.71%		3,178.13%		-222.66%		-304.03%
EBITDA Margin (Quarter)		-208.71%		3,178.13%		-222.66%		-304.03%
Operating Margin (Quarter)								-304.03%
Net Margin (Quarter)		-208.71%		3,178.13%		-222.66%		-304.03%
FCF Margin (Quarter)		-34.22%		1,027.32%		-300.98%		138.97%
Efficiency
Assets Average (Quarter)	12.61B	12.60B	9.51B	9.50B	0.02B	5.08B	5.08B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.03B	0.01B	0.01B	0.01B	0.01B	0.02B	0.03B
Invested Capital (Quarter)					-0.00B		-0.00B		-0.00B		-0.00B		-0.00B		-0.00B		-0.00B		-0.00B
Asset Utilization Ratio (Quarter)				0.00		0.00		0.35
Leverage & Solvency
Interest Coverage Ratio (Quarter)								-0.00B
Debt Ratio (Quarter)
Times Interest Earned (Quarter)								-0.00B
Dividends & Payouts
FCF Payout Ratio (Quarter)		-47.33				-1.16		4.72
Valuation
Enterprise Value (Quarter)	-0.02B	-0.02B	-0.02B	-0.02B	-0.01B	-0.01B	-0.01B	-0.01B	-0.01B	-0.03B	-0.02B	-0.03B	-0.02B	-0.02B	-0.00B	-0.01B	-0.00B	-0.00B	-0.02B	-0.03B
Return Ratios
Return on Sales (Quarter)		-0.02%		0.32%		-0.02%		-0.03%
Return on Capital Employed (Quarter)		-0.20%	-0.19%	-0.16%	-127.83%	-0.36%	-0.43%	-235.76%					-95.63%		-283.33%		-189.02%
Return on Assets (Quarter)		0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	-0.02%	-0.02%	-0.01%	0.00%		0.00%	0.00%	-0.02%	-0.03%	-0.02%	-0.02%	-0.01%	0.00%

Alterity Therapeutics ATHE Ratios (2009-2025)